Market Cap 102.13M
Revenue (ttm) 0.00
Net Income (ttm) -23.49M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 93,500
Avg Vol 303,050
Day's Range N/A - N/A
Shares Out 72.95M
Stochastic %K 68%
Beta 3.24
Analysts Strong Sell
Price Target $4.00

Company Profile

Vivani Medical, Inc., a clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates in the treatment of chronic disease and medication non-adherence. Its pipeline includes NPM-115, a high-dose exenatide implant candidate is in clinical stage development for the treatment of chronic weight management i...

Industry: Biotechnology
Sector: Healthcare
Phone: 415 506 8462
Address:
1350 South Loop Road, Alameda, United States
Mendoza_333
Mendoza_333 Dec. 4 at 3:29 AM
$VANI it's about time to do another run!!!
0 · Reply
wolfcyd3
wolfcyd3 Dec. 3 at 5:21 PM
0 · Reply
Vivani_Medical
Vivani_Medical Dec. 2 at 2:35 PM
Vivani’s R&D partnership aimed at capturing the multibillion-dollar pet obesity market is featured in the New York Times today: https://www.nytimes.com/2025/12/02/science/ozempic-glp1-pets-cats.html?smid=url-share $VANI
0 · Reply
Bagholderruined
Bagholderruined Nov. 29 at 12:58 PM
$VANI From Google search using Ai: AI Overview +9 Analysts have a mixed outlook for VANI stock, with a consensus "Hold" rating based on a small number of recent reports. While some analysts provide a price target of around $4.00, others are higher, with an average of $5.10, suggesting a potential upside ranging from roughly 193% to 286% from its current price. However, some short-term technical indicators show a sell signal due to conflicting moving averages, while others suggest a possible bounce back from oversold conditions. Short-term technical analysis Moving Averages: Short-term moving average shows a buy signal, but the long-term average indicates a sell signal because it is above the short-term average. Potential Support/Resistance: The stock may find support at $1.35 (short-term average) and face resistance at $1.50 (long-term average). Disclaimer: - I own shares and believe they have a product that can change how people and pets take meds. Spin off potential.
0 · Reply
wolfcyd3
wolfcyd3 Nov. 26 at 5:11 PM
0 · Reply
ToniesPick
ToniesPick Nov. 23 at 7:19 PM
$VANI reaching my loading zone again
0 · Reply
Romans5
Romans5 Nov. 22 at 5:09 PM
$VANI Let’s get some pump and dump action on this pos scam company
0 · Reply
m2014
m2014 Nov. 21 at 3:41 PM
0 · Reply
BC322032
BC322032 Nov. 19 at 3:51 PM
0 · Reply
Bagholderruined
Bagholderruined Nov. 19 at 11:49 AM
$VANI Accumulation at these levels. At some some point large purchases start happening really quickly.
0 · Reply
Latest News on VANI
Vivani Medical, Inc. Announces Closing of Common Stock Offering

Oct 28, 2025, 4:05 PM EDT - 5 weeks ago

Vivani Medical, Inc. Announces Closing of Common Stock Offering


Vivani Medical, Inc. Announces Pricing of Common Stock Offering

Oct 26, 2025, 7:15 PM EDT - 6 weeks ago

Vivani Medical, Inc. Announces Pricing of Common Stock Offering


Vivani Medical to Present at TIDES Conference 2024

May 9, 2024, 8:00 AM EDT - 1 year ago

Vivani Medical to Present at TIDES Conference 2024


Vivani Medical (VANI) stock price surged: is it a good buy?

Feb 29, 2024, 7:25 AM EST - 1 year ago

Vivani Medical (VANI) stock price surged: is it a good buy?


Vivani Medical to Present at BIO Investor Forum

Oct 16, 2023, 6:00 AM EDT - 2 years ago

Vivani Medical to Present at BIO Investor Forum


Vivani Medical to Present at the Boulder Peptide Symposium

Sep 7, 2023, 6:00 AM EDT - 2 years ago

Vivani Medical to Present at the Boulder Peptide Symposium


Mendoza_333
Mendoza_333 Dec. 4 at 3:29 AM
$VANI it's about time to do another run!!!
0 · Reply
wolfcyd3
wolfcyd3 Dec. 3 at 5:21 PM
0 · Reply
Vivani_Medical
Vivani_Medical Dec. 2 at 2:35 PM
Vivani’s R&D partnership aimed at capturing the multibillion-dollar pet obesity market is featured in the New York Times today: https://www.nytimes.com/2025/12/02/science/ozempic-glp1-pets-cats.html?smid=url-share $VANI
0 · Reply
Bagholderruined
Bagholderruined Nov. 29 at 12:58 PM
$VANI From Google search using Ai: AI Overview +9 Analysts have a mixed outlook for VANI stock, with a consensus "Hold" rating based on a small number of recent reports. While some analysts provide a price target of around $4.00, others are higher, with an average of $5.10, suggesting a potential upside ranging from roughly 193% to 286% from its current price. However, some short-term technical indicators show a sell signal due to conflicting moving averages, while others suggest a possible bounce back from oversold conditions. Short-term technical analysis Moving Averages: Short-term moving average shows a buy signal, but the long-term average indicates a sell signal because it is above the short-term average. Potential Support/Resistance: The stock may find support at $1.35 (short-term average) and face resistance at $1.50 (long-term average). Disclaimer: - I own shares and believe they have a product that can change how people and pets take meds. Spin off potential.
0 · Reply
wolfcyd3
wolfcyd3 Nov. 26 at 5:11 PM
0 · Reply
ToniesPick
ToniesPick Nov. 23 at 7:19 PM
$VANI reaching my loading zone again
0 · Reply
Romans5
Romans5 Nov. 22 at 5:09 PM
$VANI Let’s get some pump and dump action on this pos scam company
0 · Reply
m2014
m2014 Nov. 21 at 3:41 PM
0 · Reply
BC322032
BC322032 Nov. 19 at 3:51 PM
0 · Reply
Bagholderruined
Bagholderruined Nov. 19 at 11:49 AM
$VANI Accumulation at these levels. At some some point large purchases start happening really quickly.
0 · Reply
BostonWhalerGuyI
BostonWhalerGuyI Nov. 19 at 12:09 AM
0 · Reply
BC322032
BC322032 Nov. 18 at 4:10 PM
0 · Reply
myman1956
myman1956 Nov. 17 at 8:44 PM
$VANI Taking profits while you can is wise!
0 · Reply
wolfcyd3
wolfcyd3 Nov. 17 at 2:18 PM
$VANI https://za.investing.com/news/insider-trading-news/vivani-medical-director-williams-buys-198-million-in-vani-stock-93CH-3988048
0 · Reply
ENKU
ENKU Nov. 17 at 1:56 PM
0 · Reply
Kkai14
Kkai14 Nov. 17 at 1:08 PM
0 · Reply
BC322032
BC322032 Nov. 16 at 12:08 PM
0 · Reply
A_MR_E
A_MR_E Nov. 13 at 6:48 PM
0 · Reply
d_risk
d_risk Nov. 13 at 1:53 PM
$VANI - Vivani Medical Inc. Common Stock (DE) - 10Q - Updated Risk Factors VANI flags heightened risks from global economic and political instability, inflation, market disruptions, armed conflicts, sanctions, recessions, health crises, and potential impacts on its own and partners’ operations. #Healthcare #GeopoliticalInstability #MarketDisruptions #InflationImpact #GlobalRisks 🟢 Added 🟠 Removed https://d-risk.ai/VANI/10-Q/2025-11-13
1 · Reply
BC322032
BC322032 Nov. 11 at 10:03 PM
$VANI Very
0 · Reply
ballyhooo
ballyhooo Nov. 10 at 8:22 PM
$VANI Vivani Medical Announces Company Presentation, Unveils Obesity Market Strategy With New GLP-1 Implant Technology https://d1io3yog0oux5.cloudfront.net/_8b0e72ba9731939ad4ef3d445345826e/vivanimedical/db/2227/20875/pdf/Vivani+Corporate+Presentation+_+102925.pdf
1 · Reply
ballyhooo
ballyhooo Nov. 10 at 11:21 AM
$VANI next should be our CRGT shares from spin off!
0 · Reply